Hispana. Acceso en línea al Patrimonio Cultural Digital Español

Está en:  › Erregistro

3D Printed Tacrolimus Rectal Formulations Ameliorate Colitis in an Experimental Animal Model of Inflammatory Bowel Disease.

Identificadores del recurso

2227-9059

https://www.ncbi.nlm.nih.gov/pubmed/33276641

http://hdl.handle.net/20.500.11940/16389

10.3390/biomedicines8120563

33276641

36924

Jatorria

(RUNA repositorio institucional de la Consellería de Sanidade - Sergas)

Fitxa

Izenburu:: 3D Printed Tacrolimus Rectal Formulations Ameliorate Colitis in an Experimental Animal Model of Inflammatory Bowel Disease.
Tema:: CHUS; CHUO; IDIS
Deskribapen:: The aim of this study was to fabricate novel self-supporting tacrolimus suppositories using semisolid extrusion 3-dimensional printing (3DP) and to investigate their efficacy in an experimental model of inflammatory bowel disease. Blends of Gelucire 44/14 and coconut oil were employed as lipid excipients to obtain suppository formulations with self-emulsifying properties, which were then tested in a TNBS (2,4,6-trinitrobenzenesulfonic acid) induced rat colitis model. Disease activity was monitored using PET/CT medical imaging; maximum standardized uptake values (SUVmax), a measure of tissue radiotracer accumulation rate, together with body weight changes and histological assessments, were used as inflammatory indices to monitor treatment efficacy. Following tacrolimus treatment, a significant reduction in SUVmax was observed on days 7 and 10 in the rat colon sections compared to non-treated animals. Histological analysis using Nancy index confirmed disease remission. Moreover, statistical analysis showed a positive correlation (R(2) = 71.48%) between SUVmax values and weight changes over time. Overall, this study demonstrates the effectiveness of 3D printed tacrolimus suppositories to ameliorate colitis and highlights the utility of non-invasive PET/CT imaging to evaluate new therapies in the preclinical area.
Autor/Productor:: Seoane-Viaño, Iria; Gómez Lado, Noemí; Lazare Iglesias, Hector; García Otero, Xurxo; Antúnez López, José Ramón; Ruibal Morell, Alvaro; Varela Correa, Juan Jesús; Aguiar Fernández, Pablo; Basit, Abdul W; Otero-Espinar, Francisco J; González Barcia, Miguel; Goyanes, Alvaro; Luzardo-Álvarez, Asteria; Fernández Ferreiro, Anxo
Eskubideak:: Atribución 4.0 Internacional; http://creativecommons.org/licenses/by/4.0/; openAccess
Data:: 2022-03-23T08:56:17Z; 2020
Tipo de recurso:: Journal Article

oai_dc

Deskargatu XML

<?xml version="1.0" encoding="UTF-8" ?>

<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
1. <dc:title>3D Printed Tacrolimus Rectal Formulations Ameliorate Colitis in an Experimental Animal Model of Inflammatory Bowel Disease.</dc:title>
2. <dc:creator>Seoane-Viaño, Iria</dc:creator>
3. <dc:creator>Gómez Lado, Noemí</dc:creator>
4. <dc:creator>Lazare Iglesias, Hector</dc:creator>
5. <dc:creator>García Otero, Xurxo</dc:creator>
6. <dc:creator>Antúnez López, José Ramón</dc:creator>
7. <dc:creator>Ruibal Morell, Alvaro</dc:creator>
8. <dc:creator>Varela Correa, Juan Jesús</dc:creator>
9. <dc:creator>Aguiar Fernández, Pablo</dc:creator>
10. <dc:creator>Basit, Abdul W</dc:creator>
11. <dc:creator>Otero-Espinar, Francisco J</dc:creator>
12. <dc:creator>González Barcia, Miguel</dc:creator>
13. <dc:creator>Goyanes, Alvaro</dc:creator>
14. <dc:creator>Luzardo-Álvarez, Asteria</dc:creator>
15. <dc:creator>Fernández Ferreiro, Anxo</dc:creator>
16. <dc:subject>CHUS</dc:subject>
17. <dc:subject>CHUO</dc:subject>
18. <dc:subject>IDIS</dc:subject>
19. <dc:description>The aim of this study was to fabricate novel self-supporting tacrolimus suppositories using semisolid extrusion 3-dimensional printing (3DP) and to investigate their efficacy in an experimental model of inflammatory bowel disease. Blends of Gelucire 44/14 and coconut oil were employed as lipid excipients to obtain suppository formulations with self-emulsifying properties, which were then tested in a TNBS (2,4,6-trinitrobenzenesulfonic acid) induced rat colitis model. Disease activity was monitored using PET/CT medical imaging; maximum standardized uptake values (SUVmax), a measure of tissue radiotracer accumulation rate, together with body weight changes and histological assessments, were used as inflammatory indices to monitor treatment efficacy. Following tacrolimus treatment, a significant reduction in SUVmax was observed on days 7 and 10 in the rat colon sections compared to non-treated animals. Histological analysis using Nancy index confirmed disease remission. Moreover, statistical analysis showed a positive correlation (R(2) = 71.48%) between SUVmax values and weight changes over time. Overall, this study demonstrates the effectiveness of 3D printed tacrolimus suppositories to ameliorate colitis and highlights the utility of non-invasive PET/CT imaging to evaluate new therapies in the preclinical area.</dc:description>
20. <dc:date>2022-03-23T08:56:17Z</dc:date>
21. <dc:date>2022-03-23T08:56:17Z</dc:date>
22. <dc:date>2020</dc:date>
23. <dc:type>Journal Article</dc:type>
24. <dc:identifier>2227-9059</dc:identifier>
25. <dc:identifier>https://www.ncbi.nlm.nih.gov/pubmed/33276641</dc:identifier>
26. <dc:identifier>http://hdl.handle.net/20.500.11940/16389</dc:identifier>
27. <dc:identifier>10.3390/biomedicines8120563</dc:identifier>
28. <dc:identifier>33276641</dc:identifier>
29. <dc:identifier>36924</dc:identifier>
30. <dc:rights>Atribución 4.0 Internacional</dc:rights>
31. <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
32. <dc:rights>openAccess</dc:rights>
</oai_dc:dc>

edm

Deskargatu XML

<?xml version="1.0" encoding="UTF-8" ?>

<rdf:RDF schemaLocation="http://www.w3.org/1999/02/22-rdf-syntax-ns# http://www.europeana.eu/schemas/edm/EDM.xsd">
1. <ore:Aggregation about="oai:runa.sergas.gal:20.500.11940/16389">
  1. <edm:dataProvider>RUNA</edm:dataProvider>
  2. <edm:isShowAt resource="oai:runa.sergas.gal:20.500.11940/16389" />
  3. <edm:object resource="https://runa.sergas.gal/xmlui/bitstream/20.500.11940/16389/1/36924-677.pdf" />
  4. <edm:rights>http://creativecommons.org/licenses/by/4.0/</edm:rights>
  5. <edm:rights>openAccess</edm:rights>
  6. <edm:rights>Atribución 4.0 Internacional</edm:rights>
  </ore:Aggregation>
2. <edm:ProvidedCHO about="oai:runa.sergas.gal:20.500.11940/16389">
  1. <dc:title>3D Printed Tacrolimus Rectal Formulations Ameliorate Colitis in an Experimental Animal Model of Inflammatory Bowel Disease.</dc:title>
  2. <dc:creator>Seoane-Viaño, Iria</dc:creator>
  3. <dc:creator>Gómez Lado, Noemí</dc:creator>
  4. <dc:creator>Lazare Iglesias, Hector</dc:creator>
  5. <dc:creator>García Otero, Xurxo</dc:creator>
  6. <dc:creator>Antúnez López, José Ramón</dc:creator>
  7. <dc:creator>Ruibal Morell, Alvaro</dc:creator>
  8. <dc:creator>Varela Correa, Juan Jesús</dc:creator>
  9. <dc:creator>Aguiar Fernández, Pablo</dc:creator>
  10. <dc:creator>Basit, Abdul W</dc:creator>
  11. <dc:creator>Otero-Espinar, Francisco J</dc:creator>
  12. <dc:creator>González Barcia, Miguel</dc:creator>
  13. <dc:creator>Goyanes, Alvaro</dc:creator>
  14. <dc:creator>Luzardo-Álvarez, Asteria</dc:creator>
  15. <dc:creator>Fernández Ferreiro, Anxo</dc:creator>
  16. <dc:description>The aim of this study was to fabricate novel self-supporting tacrolimus suppositories using semisolid extrusion 3-dimensional printing (3DP) and to investigate their efficacy in an experimental model of inflammatory bowel disease. Blends of Gelucire 44/14 and coconut oil were employed as lipid excipients to obtain suppository formulations with self-emulsifying properties, which were then tested in a TNBS (2,4,6-trinitrobenzenesulfonic acid) induced rat colitis model. Disease activity was monitored using PET/CT medical imaging; maximum standardized uptake values (SUVmax), a measure of tissue radiotracer accumulation rate, together with body weight changes and histological assessments, were used as inflammatory indices to monitor treatment efficacy. Following tacrolimus treatment, a significant reduction in SUVmax was observed on days 7 and 10 in the rat colon sections compared to non-treated animals. Histological analysis using Nancy index confirmed disease remission. Moreover, statistical analysis showed a positive correlation (R(2) = 71.48%) between SUVmax values and weight changes over time. Overall, this study demonstrates the effectiveness of 3D printed tacrolimus suppositories to ameliorate colitis and highlights the utility of non-invasive PET/CT imaging to evaluate new therapies in the preclinical area.</dc:description>
  17. <dc:date>2022-03-23T08:56:17Z</dc:date>
  18. <dc:date>2022-03-23T08:56:17Z</dc:date>
  19. <dc:date>2020</dc:date>
  20. <dc:type>Journal Article</dc:type>
  21. <edm:type>TEXT</edm:type>
  22. <dc:identifier>2227-9059</dc:identifier>
  23. <dc:identifier>https://www.ncbi.nlm.nih.gov/pubmed/33276641</dc:identifier>
  24. <dc:identifier>http://hdl.handle.net/20.500.11940/16389</dc:identifier>
  25. <dc:identifier>10.3390/biomedicines8120563</dc:identifier>
  26. <dc:identifier>33276641</dc:identifier>
  27. <dc:identifier>36924</dc:identifier>
  28. <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
  29. <dc:rights>openAccess</dc:rights>
  30. <dc:rights>Atribución 4.0 Internacional</dc:rights>
  </edm:ProvidedCHO>
</rdf:RDF>